Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 21.34%677.45M | 4.39%638.2M | 10.45%541.54M | 4.80%2.23B | 2.34%568.93M | 0.75%558.31M | 6.45%611.38M | 10.84%490.31M | 5.16%2.13B | 6.43%555.94M |
| Net income from continuing operations | -7.07%286.27M | 5.40%290.28M | 5.40%241.51M | -19.17%616.57M | -254.79%-196M | 34.41%308.05M | 31.66%275.4M | 15.82%229.13M | -8.75%762.83M | -34.83%126.63M |
| Operating gains losses | 2,270.28%60.13M | 213.84%3.7M | 371.68%7.78M | 215.46%122.64M | 8,550.11%121.71M | -89.82%2.54M | -130.54%-3.25M | -13.66%1.65M | 308.41%38.88M | 170.92%1.41M |
| Depreciation and amortization | 7.39%315.33M | 7.82%307.66M | 10.25%289.95M | 16.00%1.16B | 27.13%321.79M | 15.44%293.64M | 13.07%285.35M | 8.07%262.98M | 9.17%1B | 4.24%253.12M |
| Remuneration paid in stock | 5.73%4.15M | -46.26%2.7M | -33.78%2.47M | 16.14%20.24M | 85.94%7.56M | -37.97%3.93M | 4.97%5.03M | 66.00%3.73M | 0.44%17.43M | -34.99%4.07M |
| Remuneration paid in stock | -9.50%18.48M | -1.82%18.52M | 6.77%23.44M | 10.58%77.89M | 16.26%16.66M | 39.44%20.42M | -18.00%18.86M | 18.86%21.95M | 10.95%70.44M | -5.06%14.33M |
| Deferred tax | 5.55%35.55M | 28.67%22.13M | 18.98%36.17M | -1,005.12%-57.29M | -509.54%-138.56M | 1,522.81%33.68M | 437.74%17.2M | 7.67%30.4M | -93.23%6.33M | -1,053.88%-22.73M |
| Other non cashItems | 140.16%10.93M | 342.80%44.92M | -24.50%12.26M | 129.77%494.41M | 193.65%495.25M | -173.19%-27.21M | 58.34%10.15M | 453.94%16.24M | 1,875.34%215.17M | 2,611.46%168.65M |
| Change In working capital | 30.41%-53.39M | -2,053.23%-51.7M | 4.93%-72.03M | -1,769.92%-209.31M | -668.27%-59.48M | -659.90%-76.72M | -95.91%2.65M | -44.02%-75.76M | -82.78%12.53M | -81.72%10.47M |
| -Change in receivables | ---- | ---- | ---- | 48.40%-10.65M | ---- | ---- | ---- | ---- | 79.48%-20.63M | ---- |
| -Change in prepaid assets | ---- | ---- | ---- | -239.93%-14.36M | ---- | ---- | ---- | ---- | 1,464.63%10.26M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | 4.87%56.71M | ---- | ---- | ---- | ---- | -67.18%54.08M | ---- |
| -Change in other working capital | ---- | ---- | ---- | -673.03%-241.01M | ---- | ---- | ---- | ---- | -434.17%-31.18M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 21.34%677.45M | 4.39%638.2M | 10.45%541.54M | 4.80%2.23B | 2.34%568.93M | 0.75%558.31M | 6.45%611.38M | 10.84%490.31M | 5.16%2.13B | 6.43%555.94M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 51.40%-413.94M | 9.31%-416.76M | 54.80%-603.21M | -99.81%-3.16B | -29.81%-513.37M | -46.60%-851.71M | -60.19%-459.53M | -320.00%-1.33B | 48.79%-1.58B | 67.81%-395.47M |
| Capital expenditure reported | -9.20%-297.17M | -31.35%-285.31M | -25.01%-212.46M | -13.06%-1.06B | -24.57%-396.69M | -22.91%-272.13M | 0.52%-217.22M | 3.32%-169.95M | -2.34%-934M | -8.18%-318.45M |
| Net business purchase and sale | 79.71%-116.57M | 46.21%-130.32M | 67.10%-380.42M | -207.90%-2.08B | -6.75%-110.6M | -59.59%-574.57M | -253.48%-242.28M | -699.68%-1.16B | 69.33%-676.79M | 88.91%-103.61M |
| Net other investing changes | 96.06%-197K | -4,608.33%-1.13M | -25.99%-10.34M | -164.99%-19.31M | -122.85%-6.08M | -1,207.08%-5M | -166.67%-24K | -411.07%-8.21M | -8.31%29.71M | 11,660.00%26.59M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 51.40%-413.94M | 9.31%-416.76M | 54.80%-603.21M | -99.81%-3.16B | -29.81%-513.37M | -46.60%-851.71M | -60.19%-459.53M | -320.00%-1.33B | 48.79%-1.58B | 67.81%-395.47M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -170.61%-239.01M | -16.57%-205.86M | -87.09%113.38M | 273.57%944.95M | 46.36%-95.41M | 1,388.59%338.48M | 45.47%-176.6M | 1,442.74%878.48M | -152.93%-544.41M | -130.77%-177.87M |
| Net issuance payments of debt | -32.33%288.83M | -20.65%-116.36M | -75.93%241.17M | 665.17%1.32B | 85.47%-13.44M | 380.80%426.84M | 60.84%-96.44M | 5,928.70%1B | -113.40%-233.39M | -114.32%-92.53M |
| Net common stock issuance | -48,541.56%-441.79M | ---389K | 13.29%324K | 153.65%2.01M | 2,713.79%816K | --912K | --0 | -62.61%286K | 100.19%794K | --29K |
| Cash dividends paid | -9.49%-81M | -10.55%-81.47M | -10.74%-81.48M | -11.70%-302.26M | -9.78%-81.01M | -12.65%-73.98M | -12.77%-73.7M | -11.83%-73.57M | -11.35%-270.6M | -12.99%-73.79M |
| Proceeds from stock option exercised by employees | 24.66%2.87M | --0 | 18.78%2.59M | 14.76%4.49M | --0 | 11.42%2.3M | --0 | 18.58%2.18M | 19.54%3.91M | 200.00%1K |
| Net other financing activities | 54.96%-7.93M | -18.26%-7.64M | 6.25%-49.23M | -73.66%-78.35M | 84.61%-1.78M | -623.86%-17.6M | 47.23%-6.46M | -178.36%-52.51M | 9.07%-45.12M | -345.67%-11.58M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -170.61%-239.01M | -16.57%-205.86M | -87.09%113.38M | 273.57%944.95M | 46.36%-95.41M | 1,388.59%338.48M | 45.47%-176.6M | 1,442.74%878.48M | -152.93%-544.41M | -130.77%-177.87M |
| Net cash flow | ||||||||||
| Beginning cash position | 39.01%267.47M | 14.60%249.45M | 7.68%198.17M | 1.47%184.04M | 19.83%238.51M | -5.84%192.41M | -9.49%217.67M | 1.47%184.04M | -17.42%181.36M | -35.46%199.03M |
| Current changes in cash | -45.67%24.49M | 162.98%15.58M | 51.16%51.71M | 1,002.48%14.7M | -129.10%-39.85M | 1,202.22%45.08M | 31.95%-24.74M | -42.19%34.21M | 103.68%1.33M | 86.43%-17.39M |
| Effect of exchange rate changes | -235.16%-1.38M | 570.33%2.44M | 24.78%-434K | -141.83%-561K | -120.24%-486K | 184.10%1.02M | -349.52%-519K | -968.52%-577K | 165.90%1.34M | 104.34%2.4M |
| End cash Position | 21.83%290.59M | 39.01%267.47M | 14.60%249.45M | 7.68%198.17M | 7.68%198.17M | 19.83%238.51M | -5.84%192.41M | -9.49%217.67M | 1.47%184.04M | 1.47%184.04M |
| Free cash from | 32.88%380.28M | -10.47%352.89M | 2.72%329.08M | -1.67%1.17B | -27.48%172.24M | -14.00%286.18M | 10.72%394.16M | 20.18%320.36M | 7.48%1.19B | 4.17%237.5M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.